Literature DB >> 20460899

Occult hepatitis B virus infection: detection and significance.

Wolfram H Gerlich1, Corinna Bremer, Mona Saniewski, Christian G Schüttler, Ulrike C Wend, Wulf R Willems, Dieter Glebe.   

Abstract

The Taormina Consensus Conference defined 'occult hepatitis B virus (HBV) infection' (OBI) as the 'presence of HBV DNA in the liver of individuals testing HBsAg-negative with currently available assays'. Most occult is the so-called 'window period' after exposure before HBV DNA appears in the blood. We identified two blood donors whose donations tested HBsAg- and HBV DNA-negative, but transmitted HBV. Both subsequently developed HBsAg and acute hepatitis. However, such cases are not considered as true OBI. A true transient OBI remains HBsAg-negative during the entire course. One case of acute OBI showed a peak viremia of 15,000 IU/ml HBV DNA and sub-borderline HBsAg, suggesting a ratio of virions to subviral particles of 1:10, whereas 'normal' cases show at peak viremia a ratio of 1:3,000. Blood donors with OBI may transmit HBV. We studied 5 blood donors with OBI and 55 of their recipients. In 22 recipients, transmission was probable, but they remained healthy. However, in 3 recipients, who were immunosuppressed at the time of transfusion, fatal fulminant hepatitis B developed. The majority of anti-HBc-positive healthy individuals have HBV DNA in the liver which may start replication under severe immunosuppression. Nine such cases are described here. OBI or reactivated HBV infections often lead to selection of HBsAg escape mutations as we could show in 11 of 14 cases. Infection of vaccinated individuals favors development of OBI as we observed in 6 blood donors. HB vaccination may solve the problem of overt HBV infection but may favor OBI. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20460899     DOI: 10.1159/000282074

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  27 in total

1.  Epidemiology of HBV S-gene mutants in the Liguria Region, Italy: Implications for surveillance and detection of new escape variants.

Authors:  Laura Sticchi; Patrizia Caligiuri; Roberto Cacciani; Cristiano Alicino; Bianca Bruzzone
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

2.  Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.

Authors:  Xianlin Ye; Tong Li; Xiaoxuan Xu; Peng Du; Jinfeng Zeng; Weigang Zhu; Baocheng Yang; Chengyao Li; Jean-Pierre Allain
Journal:  Blood Transfus       Date:  2016-05-17       Impact factor: 3.443

Review 3.  Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus.

Authors:  Venkatakrishna Shyamala
Journal:  Asian J Transfus Sci       Date:  2014-01

4.  Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China.

Authors:  Yang Yong-Lin; Fu Qiang; Zhang Ming-Shun; Cai Jie; Ma Gui-Ming; Huang Zu-Hu; Cai Xu-Bing
Journal:  Virol J       Date:  2012-04-14       Impact factor: 4.099

Review 5.  Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing.

Authors:  Antonella Esposito; Chiara Sabia; Carmela Iannone; Giovanni F Nicoletti; Linda Sommese; Claudio Napoli
Journal:  Transfus Med Hemother       Date:  2017-05-05       Impact factor: 3.747

6.  One window-period donation in two years of individual donor-nucleic acid test screening for hepatitis B, hepatitis C and human immunodeficiency virus.

Authors:  José Eduardo Levi; Ricardo Antonio D'Almeida Pereira; Márcia Bernardino de Carvalho Polite; Mariza Aparecida Mota; Silvia Patricia Nunez; João Renato Rebello Pinho; José Mauro Kutner
Journal:  Rev Bras Hematol Hemoter       Date:  2013

Review 7.  Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.

Authors:  Wolfram H Gerlich
Journal:  Med Microbiol Immunol       Date:  2014-12-19       Impact factor: 3.402

8.  Hepatitis B virus surface antigen (HBsAg)-positive and HBsAg-negative hepatitis B virus infection among mother-teenager pairs 13 years after neonatal hepatitis B virus vaccination.

Authors:  Qing-Qing Yao; Xiao-Lian Dong; Xue-Cai Wang; Sheng-Xiang Ge; An-Qun Hu; Hai-Yan Liu; Yueping Alex Wang; Quan Yuan; Ying-Jie Zheng
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

9.  Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China.

Authors:  Yong Liu; Ping Li; Cuiping Li; Jinyong Zhou; Chao Wu; Yi-Hua Zhou
Journal:  Virol J       Date:  2010-08-19       Impact factor: 4.099

10.  Characteristics of hepatitis B infection in a sample of omani patients.

Authors:  Khalid Al-Naamani; Ali Al-Maqbali; Siham Al-Sinani
Journal:  Sultan Qaboos Univ Med J       Date:  2013-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.